Search

Search Constraints

You searched for: Author/Creator Xicoy, B.

Search Results

1. 119 UPDATE ON THE MULTICENTER MDS BIOREGISTRY PROJECT OF THE "KREBSHILFE-VERBUNDFORSCHUNGSPROJEKT MDS" OF THE GERMAN MDS STUDY GROUP. Issue 1 (April 2015)

2. 83 PERCENTAGE OF BLASTS IN CHRONIC MYELOMONOCYTIC LEUKEMIA TYPE-1 HAS NO IMPACT ON OVERALL SURVIVAL IN A SERIES OF PATIENTS FROM THE SPANISH REGISTRY OF MDS. (April 2015)

3. 90 INTENSIVE CHEMOTHERAPY VERSUS NO INTENSIVE TREATMENT IN HIGH RISK MYELODYSPLASTYC SYNDROME (MDS) NO-HSCT CANDIDATES. (April 2015)

4. Calculating IPSS-R by Enumerating Bone Marrow Blasts from Nonerythroid Cellularity Improves Outcome Prediction in MDS with Erythroid Predominance. (April 2017)

6. Impact of anaemia on health‐related quality of life and cardiac remodelling in patients with lower risk myelodysplastic syndromes. Results of GlobQoL study. (4th January 2016)

7. Mutational Signature and Clonal Architecture of Low Risk Myelodysplastic Syndromes with Del(5Q). (April 2017)

9. P728: GENE EXPRESSION PROFILE REVELS T-LYMPHOCYTES ACTIVATION THROUGH CELL CYCLE PROGRESSION AND MITOCHONDRIAL METABOLISM REGULATION IN MYELODYSPLASTIC SYNDROMES WITH DEL(5Q) AFTER LENALIDOMIDE TREATMENT. (23rd June 2022)

10. P768: GUADECITABINE (SGI-110) VS. TREATMENT CHOICE (TC) IN RELAPSED/REFRACTORY(R/R) MYELODYSPLASTIC SYNDROME (MDS), RESULTS OF A GLOBAL, RANDOMIZED, PHASE 3 STUDY. (23rd June 2022)